UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy

Frontiers in immunology, 2023-01, Vol.13, p.1129001-1129001

2023

Volltextzugriff (PDF)

S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab

Molecular cancer therapeutics, 2013-09, Vol.12 (9), p.1749-1762

2013

Volltextzugriff (PDF)

Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

Nature communications, 2016-09, Vol.7 (1), p.12602-12602, Article 12602

2016

Volltextzugriff (PDF)

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

Blood, 2021-02, Vol.137 (7), p.877-887

2021

Volltextzugriff (PDF)

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease

PLoS biology, 2014-04, Vol.12 (4), p.e1001833-e1001833

2014

Volltextzugriff (PDF)

Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment

Bulletin du cancer, 2018-11, Vol.105 (11), p.1033-1041

2018

Volltextzugriff (PDF)

Pembrolizumab for the treatment of colorectal cancer

Expert opinion on biological therapy, 2020-03, Vol.20 (3), p.219-226

2020

Volltextzugriff (PDF)

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

Annals of hematology, 2020-07, Vol.99 (7), p.1595-1604

2020

Volltextzugriff (PDF)

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer

Oncoimmunology, 2022-12, Vol.11 (1), p.2046931-2046931

2022

Volltextzugriff (PDF)

Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels

Blood, 2014-11, Vol.124 (19), p.2983-2986

2014

Volltextzugriff (PDF)

Applicability of mono dysplasia score on the new Sysmex XR analyzer range to predict diagnosis of chronic myelomonocytic leukaemia

International journal of laboratory hematology, 2024-04

2024

Volltextzugriff (PDF)

Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay

PloS one, 2019-08, Vol.14 (8), p.e0221123-e0221123

2019

Volltextzugriff (PDF)

Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist's Point of View

Cancers, 2023-07, Vol.15 (15), p.3811

2023

Volltextzugriff (PDF)

CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

PLoS biology, 2014-04, Vol.12 (4)

2014

Volltextzugriff (PDF)

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

Modern pathology, 2022-08, Vol.35 (8), p.1126-1136

2022

Volltextzugriff (PDF)

Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability–High Metastatic Colorectal Cancer

Clinical colorectal cancer, 2020-12, Vol.19 (4), p.e183-e188

2020

Volltextzugriff (PDF)

Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management

Journal of the American Academy of Dermatology, 2022-05, Vol.86 (5), p.1042-1048

2022

Volltextzugriff (PDF)

Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases

Gastroenterology (New York, N.Y. 1943), 2018-10, Vol.155 (4), p.1205-1217

2018

Volltextzugriff (PDF)

Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay

The Journal of molecular diagnostics : JMD, 2021-08, Vol.23 (8), p.929-940

2021

Volltextzugriff (PDF)

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

Human vaccines & immunotherapeutics, 2021-10, Vol.17 (10), p.3511-3514

2021

Volltextzugriff (PDF)

Synthesis of Cis-fused pyran indolocarbazole derivatives that inhibit FLT3 kinase and the DNA damage kinase, checkpoint kinase 1

Anti-cancer agents in medicinal chemistry, 2012-03, Vol.12 (3), p.194

2012

Volltextzugriff (PDF)

Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy

Cancers, 2022-09, Vol.14 (17), p.4261

2022

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(18)
Journal Of Clinical Oncology
(8)
Haematologica
(5)
Plos Biology
(5)
Acta Dermato-Venereologica
(4)
Cancer Research
(4)
Cellular And Molecular Gastroenterology And Hepatology
(4)
Gastroenterology
(4)
Cancers
(3)
Ebiomedicine
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy

ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study

S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab

Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease

Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment

Pembrolizumab for the treatment of colorectal cancer

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer

Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels

Applicability of mono dysplasia score on the new Sysmex XR analyzer range to predict diagnosis of chronic myelomonocytic leukaemia

Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay

Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist's Point of View

CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability–High Metastatic Colorectal Cancer

Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay

Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management

Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases

Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

Synthesis of Cis-fused pyran indolocarbazole derivatives that inhibit FLT3 kinase and the DNA damage kinase, checkpoint kinase 1

Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy

Suchergebnisse filtern